Lytenava

Medicinal product

(Invented) name

Lytenava

Active substance (s)

Bevacizumabas gama

Strength

25 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA08, bevacizumab

Marketing authorisation holder

Outlook Therapeutics Limited, Airija

Date of authorisation

2024-05-27

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Kiekviename tirpalo mililitre yra	1 ml
Bevacizumabas gama	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
113787	99904	1099904	flakonas	0,3 ml N1		Receptinis	EU/1/24/1798/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-05-27	Registruotas